Zobrazeno 1 - 10
of 394
pro vyhledávání: ''
Autor:
Nikola Šutulović, Nela Puškaš, Olivera Stanojlović, Djurdja Jerotic, Djuro Macut, Dragan Hrnčić, Sonja Suvakov, Aleksandra Rašić-Marković, Tatjana Simic, Željko Grubač
Publikováno v:
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity
Sleep architecture alterations, among which sleep fragmentation is highly prevalent, represent risk factors for a variety of diseases, ranging from cardiovascular to brain disorders, including anxiety. What mediates anxiety occurrence upon sleep frag
Autor:
Sang Kyum Kim, Ji Hye Im, Suntae Kim, Wankyu Kim, Sun Jo Kim, Young Jae Choi, Ji-Yoon Lee, Sung Won Kwon, Keon Wook Kang
Publikováno v:
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity
Background. Although the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR- TKI) therapy has been proven in non-small cell lung cancer (NSCLC) patients, acquired resistance to EGFR-TKIs presents a serious clinical problem.
Publikováno v:
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Despite advances in the drug treatment strategy for stable coronary heart disease (CHD), the mortality of CHD continues to rise. New or adjuvant treatments would be desirable for CHD. Xuefu Zhuyu granules are derived from the formula of traditional C
Autor:
Yih Giun Cherng, Oluwaseun Adebayo Bamodu, Shiue Wei Lai, Ming Yao Chen, Chi Tai Yeh, Ming Shou Hsieh, Ting Yi Huang, Wei Hwa Lee
Publikováno v:
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity
Background. Treating advanced colon cancer remains challenging in clinical settings because of the development of drug resistance and distant metastasis. Mechanisms underlying the metastasis of colon cancer are complex and unclear. Methods. Computati
Autor:
Natalia Pawlas, Kamila Osadnik, Grzegorz K Jakubiak, Sławomir Kasperczyk, Mateusz Lejawa, Tadeusz Osadnik
Publikováno v:
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Introduction. Obesity is one of the most important public health problems in the world. Among obese people, there are those who, apart from excessive body weight, do not exhibit other metabolic dysfunctions, have a lower risk of developing cardiovasc
Autor:
Aleksandra Klisic, Svetozar Putnik, Natasa Bogavac-Stanojevic, Luka Babic, Milos Matkovic, Vojislava Neskovic, Aleksandar Mikic, Petar Vukicevic, Nemanja Aleksic, Jelena Kotur-Stevuljevic
Publikováno v:
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity
Objective. Recent studies have shown that the red cell distribution width- (RDW-) to-platelet (PLT) count ratio (i.e., RPR) and the mean platelet volume (MPV)/PLT ratio (i.e. MPR) are more sensitive markers of atherosclerosis-connected risk than RDW
Autor:
Tomasz Kozłowski, Mateusz Maciejczyk, Anna Starzyńska, Magdalena Łuba, Piotr Myśliwiec, Hanna Myśliwiec, Anna Zalewska, Katarzyna Choromańska, Barbara Choromańska, Anna Gibała, Jacek Dadan, Małgorzata Żendzian-Piotrowska, Piotr Wojskowicz
Publikováno v:
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
This study is the first to assess redox balance, glutathione metabolism, and oxidative damage to RNA/DNA, proteins, and lipids in the plasma/serum and urine of patients with adrenal masses. The study included 70 patients with adrenal tumors divided i
Autor:
Shi Liang, Lisui Zhang, Zhi-Teng Chen, Ya-Jing Wang, Junxiong Qiu, Zhuzhi Wen, Yuan Fu, Feng Wei, Diefei Liang, Ling Li
Publikováno v:
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Atherosclerosis (AS) is a chronic metabolic disease in arterial walls, characterized by lipid deposition and persistent aseptic inflammation. AS is regarded as the basis of a variety of cardiovascular and cerebrovascular diseases. It is widely acknow
Autor:
Jing Bai, Xiaoye Xie, Li Fan, Kun Lin, Yang Li, Jianwei Liu, Xue Yang, Chuanbin Liu, Zihao Fu, Qing Dan, Xu Lu
Publikováno v:
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
The incidence of atrial fibrillation (AF) increases with age, and telomere length gradually shortens with age. However, whether telomere length is related to AF is still inconclusive, and the exact mechanism by which aging causes the increased incide
Autor:
Yang Luan, Bintao Hu, Bo Liu, Xiaming Liu, Xian Wei, Yue Wu, Zhuo Liu, Jihong Liu, Tao Wang, Yajun Ruan, Huan Feng
Publikováno v:
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
The imbalance of the redox system has been shown to be closely related to the occurrence and progression of many cancers. However, the biological function and clinical significance of redox-related genes (RRGs) in clear cell renal cell carcinoma (ccR